Nasopharyngeal microbiota in hospitalized children with Bordetella pertussis and Rhinovirus infection

A E Tozzi1, F Del Chierico2, E Pandolfi1

  • 1Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio, 4, 00165, Rome, Italy.

Scientific Reports
|November 25, 2021
PubMed

Insights

The infant nasopharyngeal microbiota differs between Bordetella pertussis (Bp) and Rhinovirus (Rv) infections, with coinfection reducing microbial diversity. Early life factors influence this microbiota, impacting susceptibility and severity of Bp and Rv infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatrics

Background:

  • The role of the host microbiota in Bordetella pertussis (Bp) pathogenesis is largely unexplored.
  • The microbiota is crucial for defense against respiratory bacterial and viral infections.

Purpose of the Study:

  • To investigate nasopharyngeal microbiota profiles in infants with B. pertussis (Bp), Rhinovirus (Rv), or co-infections (Bp+Rv).
  • To identify correlations between host factors and microbiota composition during these infections.

Main Methods:

  • Nasopharyngeal microbiota profiling using 16S rRNA gene sequencing.
  • Comparative analysis of microbial communities across infection groups (Bp, Rv, Bp+Rv).
  • Correlation analysis between clinical data and microbiota profiles.

Main Results:

  • Distinct nasopharyngeal microbiome profiles were observed for Bp, Rv, and Bp+Rv groups.
  • Coinfection (Bp+Rv) led to reduced microbial richness compared to single infections.
  • Specific bacterial families (Alcaligenaceae, Achromobacter, Moraxellaceae, Moraxella) showed differential abundance.
  • Delivery and feeding methods, and antibiotic use, correlated with Bp infection and microbiota alterations.
  • A classification model identified specific microbiota fingerprints for Bp and Rv infections.

Conclusions:

  • Early-life external factors significantly shape the nasopharyngeal microbiota, influencing susceptibility to Bp and Rv infections.
  • Infections alter the microbiota, promoting the overgrowth of pathobionts, which may contribute to disease severity.

Related Concept Videos

Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
1.3K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
2.0K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
6.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
388
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
495